Hypothesis

7 Matching Annotations

May 2026
www.nature.com www.nature.com

SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

1
1. scibot 15 May 2026
  
  in Public
  
  RRID:AB_2114429
  
  DOI: 10.1038/s42003-026-09678-9
  
  Resource: (Proteintech Cat# 13588-1-AP, RRID:AB_2114429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2114429
  
  What is this?
  
  RRID:AB_2114429
Visit annotations in context

Tags

RRID:AB_2114429

Annotators

scibot

URL

nature.com/articles/s42003-026-09678-9
Mar 2026
www.sciencedirect.com www.sciencedirect.com

LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling

1
1. scibot 10 Mar 2026
  
  in Public
  
  RRID:AB_2114429
  
  DOI: 10.1016/j.xcrm.2026.102658
  
  Resource: (Proteintech Cat# 13588-1-AP, RRID:AB_2114429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2114429
  
  What is this?
  
  RRID:AB_2114429
Visit annotations in context

Tags

RRID:AB_2114429

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379126000753
Jan 2026
www.sciencedirect.com www.sciencedirect.com

METTL3/CD98-mediated glutamate efflux in CAFs drives CD8+ T cell exhaustion and impedes neoadjuvant immunochemotherapy

1
1. scibot 29 Jan 2026
  
  in Public
  
  RRID:AB_2114429
  
  DOI: 10.1016/j.celrep.2026.116933
  
  Resource: (Proteintech Cat# 13588-1-AP, RRID:AB_2114429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2114429
  
  What is this?
  
  RRID:AB_2114429
Visit annotations in context

Tags

RRID:AB_2114429

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124726000112
Sep 2025
www.sciencedirect.com www.sciencedirect.com

HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer

1
1. scibot 24 Sep 2025
  
  in Public
  
  RRID:AB_2114429
  
  DOI: 10.1016/j.cmet.2025.08.009
  
  Resource: (Proteintech Cat# 13588-1-AP, RRID:AB_2114429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2114429
  
  What is this?
  
  RRID:AB_2114429
Visit annotations in context

Tags

RRID:AB_2114429

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1550413125003821
Apr 2025
www.sciencedirect.com www.sciencedirect.com

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer

1
1. scibot 11 Apr 2025
  
  in Public
  
  RRID:AB_2114429
  
  DOI: 10.1016/j.ccell.2025.03.017
  
  Resource: (Proteintech Cat# 13588-1-AP, RRID:AB_2114429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2114429
  
  What is this?
  
  RRID:AB_2114429
Visit annotations in context

Tags

RRID:AB_2114429

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610825001187
Jan 2025
www.sciencedirect.com www.sciencedirect.com

Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1

1
1. scibot 14 Jan 2025
  
  in Public
  
  RRID:AB_2114429
  
  DOI: 10.1016/j.cmet.2024.11.012
  
  Resource: (Proteintech Cat# 13588-1-AP, RRID:AB_2114429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2114429
  
  What is this?
  
  RRID:AB_2114429
Visit annotations in context

Tags

RRID:AB_2114429

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1550413124004807
Dec 2024
52.53.155.43 52.53.155.43

ANLN promotes head and neck squamous cell carcinoma progression by upregulating PD-L1 via the ERK-MAPK pathway-html.html

1
1. scibot 19 Dec 2024
  
  in Public
  
  RRID:AB_2114429
  
  DOI: 10.1016/j.isci.2024.111633
  
  Resource: (Proteintech Cat# 13588-1-AP, RRID:AB_2114429)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2114429
  
  What is this?
  
  RRID:AB_2114429
Visit annotations in context

Tags

RRID:AB_2114429

Annotators

scibot

URL

52.53.155.43/7324a4302b92926502f88e0cd10bf0b0ca3de710/ANLN promotes head and neck squamous cell carcinoma progression by upregulating PD-L1 via the ERK-MAPK pathway-html.html